Logo image of FCRD

FIRST EAGLE ALTERNATIVE CAPI (FCRD) Stock Fundamental Analysis

USA - NASDAQ:FCRD - US26943B1008 - Common Stock

4.54 USD
-0.17 (-3.61%)
Last: 3/9/2023, 8:21:12 PM
Fundamental Rating

3

FCRD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 236 industry peers in the Capital Markets industry. Both the profitability and financial health of FCRD have multiple concerns. FCRD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

FCRD had positive earnings in the past year.
FCRD had a positive operating cash flow in the past year.
FCRD Yearly Net Income VS EBIT VS OCF VS FCFFCRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

The profitability ratios for FCRD are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FCRD Yearly ROA, ROE, ROICFCRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 -5 -10 -15

1.3 Margins

In the last couple of years the Profit Margin of FCRD has grown nicely.
FCRD's Operating Margin has improved in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for FCRD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y10.62%
PM growth 3YN/A
PM growth 5Y8.88%
GM growth 3YN/A
GM growth 5YN/A
FCRD Yearly Profit, Operating, Gross MarginsFCRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -2K -4K -6K -8K

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for FCRD remains at a similar level compared to 1 year ago.
The debt/assets ratio for FCRD is higher compared to a year ago.
FCRD Yearly Shares OutstandingFCRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
FCRD Yearly Total Debt VS Total AssetsFCRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.86, we must say that FCRD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.86, FCRD is doing worse than 89.27% of the companies in the same industry.
The Debt to FCF ratio of FCRD is 22.28, which is on the high side as it means it would take FCRD, 22.28 years of fcf income to pay off all of its debts.
FCRD has a Debt to FCF ratio (22.28) which is comparable to the rest of the industry.
FCRD has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
FCRD's Debt to Equity ratio of 1.43 is on the low side compared to the rest of the industry. FCRD is outperformed by 71.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 22.28
Altman-Z -0.86
ROIC/WACCN/A
WACCN/A
FCRD Yearly LT Debt VS Equity VS FCFFCRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M 400M

2.3 Liquidity

FCRD has a Current Ratio of 2.45. This indicates that FCRD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.45, FCRD is in the better half of the industry, outperforming 79.51% of the companies in the same industry.
FCRD has a Quick Ratio of 2.45. This indicates that FCRD is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.45, FCRD is doing good in the industry, outperforming 79.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.45
FCRD Yearly Current Assets VS Current LiabilitesFCRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.00% over the past year.
Measured over the past years, FCRD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.59% on average per year.
Looking at the last year, FCRD shows a very negative growth in Revenue. The Revenue has decreased by -125.91% in the last year.
FCRD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.57% yearly.
EPS 1Y (TTM)0%
EPS 3Y-27.96%
EPS 5Y-21.59%
EPS Q2Q%18.18%
Revenue 1Y (TTM)-125.91%
Revenue growth 3Y19.37%
Revenue growth 5Y-7.57%
Sales Q2Q%-52.49%

3.2 Future

The Earnings Per Share is expected to grow by 6.22% on average over the next years.
FCRD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.21% yearly.
EPS Next Y15.6%
EPS Next 2Y14.78%
EPS Next 3Y6.22%
EPS Next 5YN/A
Revenue Next Year2%
Revenue Next 2Y11.28%
Revenue Next 3Y6.21%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FCRD Yearly Revenue VS EstimatesFCRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
FCRD Yearly EPS VS EstimatesFCRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

FCRD is valuated reasonably with a Price/Earnings ratio of 10.81.
FCRD's Price/Earnings ratio is a bit cheaper when compared to the industry. FCRD is cheaper than 64.39% of the companies in the same industry.
FCRD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.67.
A Price/Forward Earnings ratio of 8.61 indicates a reasonable valuation of FCRD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FCRD indicates a somewhat cheap valuation: FCRD is cheaper than 66.83% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.33, FCRD is valued rather cheaply.
Industry RankSector Rank
PE 10.81
Fwd PE 8.61
FCRD Price Earnings VS Forward Price EarningsFCRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

71.71% of the companies in the same industry are more expensive than FCRD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.76
EV/EBITDA N/A
FCRD Per share dataFCRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y14.78%
EPS Next 3Y6.22%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.46%, FCRD is a good candidate for dividend investing.
FCRD's Dividend Yield is a higher than the industry average which is at 8.56.
Compared to an average S&P500 Dividend Yield of 2.35, FCRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.46%

5.2 History

The dividend of FCRD decreases each year by -28.19%.
FCRD has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)-28.19%
Div Incr Years2
Div Non Decr Years2
FCRD Yearly Dividends per shareFCRD Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 0.1 0.2 0.3 0.4

5.3 Sustainability

FCRD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-42.75%
EPS Next 2Y14.78%
EPS Next 3Y6.22%
FCRD Yearly Income VS Free CF VS DividendFCRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M 100M

More info and screens

FIRST EAGLE ALTERNATIVE CAPI

NASDAQ:FCRD (3/9/2023, 8:21:12 PM)

4.54

-0.17 (-3.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-09 2023-03-09
Earnings (Next)05-08 2023-05-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap135.85M
Revenue(TTM)-10058000
Net Income(TTM)-28778000
Analysts45.71
Price Target4.59 (1.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.46%
Yearly Dividend0.4
Dividend Growth(5Y)-28.19%
DP-42.75%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.25%
Min EPS beat(2)-1.96%
Max EPS beat(2)12.46%
EPS beat(4)1
Avg EPS beat(4)-2.65%
Min EPS beat(4)-15.97%
Max EPS beat(4)12.46%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-187.43%
Min Revenue beat(2)-313.57%
Max Revenue beat(2)-61.3%
Revenue beat(4)0
Avg Revenue beat(4)-132%
Min Revenue beat(4)-313.57%
Max Revenue beat(4)-55.66%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.81
Fwd PE 8.61
P/S N/A
P/FCF 13.76
P/OCF 13.76
P/B 0.88
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)0.42
EY9.25%
EPS(NY)0.53
Fwd EY11.61%
FCF(TTM)0.33
FCFY7.27%
OCF(TTM)0.33
OCFY7.27%
SpS-0.34
BVpS5.14
TBVpS5.14
PEG (NY)0.69
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y10.62%
PM growth 3YN/A
PM growth 5Y8.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover-0.03
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 22.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 2.45
Altman-Z -0.86
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.96%
EPS 5Y-21.59%
EPS Q2Q%18.18%
EPS Next Y15.6%
EPS Next 2Y14.78%
EPS Next 3Y6.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-125.91%
Revenue growth 3Y19.37%
Revenue growth 5Y-7.57%
Sales Q2Q%-52.49%
Revenue Next Year2%
Revenue Next 2Y11.28%
Revenue Next 3Y6.21%
Revenue Next 5YN/A
EBIT growth 1Y-239.48%
EBIT growth 3YN/A
EBIT growth 5Y2.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.06%
OCF growth 3YN/A
OCF growth 5YN/A